Literature DB >> 7517359

Induction of B cell costimulatory function by recombinant murine CD40 ligand.

M K Kennedy1, K M Mohler, K D Shanebeck, P R Baum, K S Picha, C A Otten-Evans, C A Janeway, K H Grabstein.   

Abstract

T cell-dependent regulation of B cell growth and differentiation involves an interaction between CD40, a B cell surface molecule, and the CD40 ligand (CD40L) which is expressed on activated CD4+ T cells. In the current study, we show that recombinant membrane-bound murine CD40L induces B cells to express costimulatory function for the proliferation of CD4+ T cells. CD40L- or lipopolysaccharide (LPS)-activated, but not control-cultured B cells were strong costimulators of anti-CD3 or alloantigen-dependent T cell responses. The molecular interactions responsible for the increased costimulatory functions were examined by analyzing the activated B cells for changes in the expression of two costimulatory molecules, B7 and heat-stable antigen (HSA), as well as by the use of antagonists of B7 and HSA (CTLA4.Fc and 20C9, respectively). The expression of both B7 and HSA was enhanced on B cells activated with LPS. As observed in previous studies, the costimulatory activity of the LPS-activated B cells was dependent on both B7 and HSA and was completely inhibited in the presence of a combination of CTLA4.Fc and 20C9. In contrast, activation of B cells with CD40L induced the expression of B7 but did not enhance the expression of HSA. In addition the costimulatory activity of the CD40L-activated B cells was partially, but not completely, inhibited by the combination of CTLA4.Fc and 20C9. These results demonstrate that CD40L regulates costimulatory function of B cells in part by inducing the expression of B7 and suggest that CD40L-activated B cells express an additional costimulatory activity that is not associated with LPS-activated B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517359     DOI: 10.1002/eji.1830240118

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.

Authors:  G A Holländer; E Castigli; R Kulbacki; M Su; S J Burakoff; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

3.  Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

Authors:  Y Guo; Y Wu; S Shinde; M S Sy; A Aruffo; Y Liu
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes.

Authors:  Y Liu; R H Wenger; M Zhao; P J Nielsen
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

5.  Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.

Authors:  A Jain; T P Atkinson; P E Lipsky; J E Slater; D L Nelson; W Strober
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.

Authors:  L Chen; S-X Lin; L Overbergh; C Mathieu; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.

Authors:  L Leifeld; C Trautwein; F L Dumoulin; M P Manns; T Sauerbruch; U Spengler
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

8.  Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction.

Authors:  G Carayanniotis; S R Masters; R J Noelle
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

9.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Authors:  A Desai-Mehta; L Lu; R Ramsey-Goldman; S K Datta
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

10.  Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

Authors:  D C Parker; D L Greiner; N E Phillips; M C Appel; A W Steele; F H Durie; R J Noelle; J P Mordes; A A Rossini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.